The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Oncolytic Virus Therapy-Global Market Insights and Sales Trends 2025

Oncolytic Virus Therapy-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1823921

No of Pages : 103

Ask Your Query

Synopsis

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn’t until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

The global Oncolytic Virus Therapy market size is expected to reach US$ 29 million by 2029, growing at a CAGR of 24.9% from 2023 to 2029. The market is mainly driven by the significant applications of Oncolytic Virus Therapy in various end use industries.

The expanding demands from the Melanoma, Prostate Cancer, Breast Cancer and Ovarian Cancer, are propelling Oncolytic Virus Therapy market. HSV-based Oncolytic Viruses, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Adenoviruses-based Oncolytic Viruses segment is estimated at % CAGR for the next seven-year period.
Amgen, Colytics Biotech, Iralytics and Ransgene SA are the leading providers of oncolytic virus therapy, with the first 3 accounting for about 60% of the market.
North America and Europe are the main markets, each accounting for about 40% of the market.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oncolytic Virus Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Oncolytic Virus Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Oncolytic Virus Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oncolytic Virus Therapy sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Oncolytic Virus Therapy covered in this report include Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics and Sorrento Therapeutics, etc.

The global Oncolytic Virus Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Amgen
  • Oncolytics Biotech
  • Viralytics
  • Transgene SA
  • Oncolys BioPharma
  • Targovax
  • PsiOxus Therapeutics
  • SillaJen Biotherapeutics
  • Sorrento Therapeutics
  • Lokon Pharma
  • Genelux Corporation
  • Vyriad
  • TILT Biotherapeutics
  • Cold Genesys

Global Oncolytic Virus Therapy market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Oncolytic Virus Therapy market, Segment by Type:

  • HSV-based Oncolytic Viruses
  • Adenoviruses-based Oncolytic Viruses
  • Vaccinia Virus-based Oncolytic Viruses
  • Vesicular Stomatitis Virus-based Oncolytic Viruses
  • Newcastle Disease Virus-based Oncolytic Viruses

Global Oncolytic Virus Therapy market, by Application

  • Melanoma
  • Prostate Cancer
  • Breast Cancer
  • Ovarian Cancer
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Oncolytic Virus Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Oncolytic Virus Therapy
1.1 Oncolytic Virus Therapy Market Overview
1.1.1 Oncolytic Virus Therapy Product Scope
1.1.2 Oncolytic Virus Therapy Market Status and Outlook
1.2 Global Oncolytic Virus Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Oncolytic Virus Therapy Market Size by Region (2018-2029)
1.4 Global Oncolytic Virus Therapy Historic Market Size by Region (2018-2023)
1.5 Global Oncolytic Virus Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Oncolytic Virus Therapy Market Size (2018-2029)
1.6.1 North America Oncolytic Virus Therapy Market Size (2018-2029)
1.6.2 Europe Oncolytic Virus Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Oncolytic Virus Therapy Market Size (2018-2029)
1.6.4 Latin America Oncolytic Virus Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Oncolytic Virus Therapy Market Size (2018-2029)
2 Oncolytic Virus Therapy Market by Type
2.1 Introduction
2.1.1 HSV-based Oncolytic Viruses
2.1.2 Adenoviruses-based Oncolytic Viruses
2.1.3 Vaccinia Virus-based Oncolytic Viruses
2.1.4 Vesicular Stomatitis Virus-based Oncolytic Viruses
2.1.5 Newcastle Disease Virus-based Oncolytic Viruses
2.2 Global Oncolytic Virus Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Oncolytic Virus Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Oncolytic Virus Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Oncolytic Virus Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Oncolytic Virus Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Oncolytic Virus Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Oncolytic Virus Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Oncolytic Virus Therapy Revenue Breakdown by Type (2018-2029)
3 Oncolytic Virus Therapy Market Overview by Application
3.1 Introduction
3.1.1 Melanoma
3.1.2 Prostate Cancer
3.1.3 Breast Cancer
3.1.4 Ovarian Cancer
3.1.5 Others
3.2 Global Oncolytic Virus Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Oncolytic Virus Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Oncolytic Virus Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Oncolytic Virus Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Oncolytic Virus Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Oncolytic Virus Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Oncolytic Virus Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Oncolytic Virus Therapy Revenue Breakdown by Application (2018-2029)
4 Oncolytic Virus Therapy Competition Analysis by Players
4.1 Global Oncolytic Virus Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncolytic Virus Therapy as of 2022)
4.3 Date of Key Players Enter into Oncolytic Virus Therapy Market
4.4 Global Top Players Oncolytic Virus Therapy Headquarters and Area Served
4.5 Key Players Oncolytic Virus Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Oncolytic Virus Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Amgen
5.1.1 Amgen Profile
5.1.2 Amgen Main Business
5.1.3 Amgen Oncolytic Virus Therapy Products, Services and Solutions
5.1.4 Amgen Oncolytic Virus Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Amgen Recent Developments
5.2 Oncolytics Biotech
5.2.1 Oncolytics Biotech Profile
5.2.2 Oncolytics Biotech Main Business
5.2.3 Oncolytics Biotech Oncolytic Virus Therapy Products, Services and Solutions
5.2.4 Oncolytics Biotech Oncolytic Virus Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Oncolytics Biotech Recent Developments
5.3 Viralytics
5.3.1 Viralytics Profile
5.3.2 Viralytics Main Business
5.3.3 Viralytics Oncolytic Virus Therapy Products, Services and Solutions
5.3.4 Viralytics Oncolytic Virus Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Transgene SA Recent Developments
5.4 Transgene SA
5.4.1 Transgene SA Profile
5.4.2 Transgene SA Main Business
5.4.3 Transgene SA Oncolytic Virus Therapy Products, Services and Solutions
5.4.4 Transgene SA Oncolytic Virus Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Transgene SA Recent Developments
5.5 Oncolys BioPharma
5.5.1 Oncolys BioPharma Profile
5.5.2 Oncolys BioPharma Main Business
5.5.3 Oncolys BioPharma Oncolytic Virus Therapy Products, Services and Solutions
5.5.4 Oncolys BioPharma Oncolytic Virus Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Oncolys BioPharma Recent Developments
5.6 Targovax
5.6.1 Targovax Profile
5.6.2 Targovax Main Business
5.6.3 Targovax Oncolytic Virus Therapy Products, Services and Solutions
5.6.4 Targovax Oncolytic Virus Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 Targovax Recent Developments
5.7 PsiOxus Therapeutics
5.7.1 PsiOxus Therapeutics Profile
5.7.2 PsiOxus Therapeutics Main Business
5.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Products, Services and Solutions
5.7.4 PsiOxus Therapeutics Oncolytic Virus Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 PsiOxus Therapeutics Recent Developments
5.8 SillaJen Biotherapeutics
5.8.1 SillaJen Biotherapeutics Profile
5.8.2 SillaJen Biotherapeutics Main Business
5.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Products, Services and Solutions
5.8.4 SillaJen Biotherapeutics Oncolytic Virus Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 SillaJen Biotherapeutics Recent Developments
5.9 Sorrento Therapeutics
5.9.1 Sorrento Therapeutics Profile
5.9.2 Sorrento Therapeutics Main Business
5.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Products, Services and Solutions
5.9.4 Sorrento Therapeutics Oncolytic Virus Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Sorrento Therapeutics Recent Developments
5.10 Lokon Pharma
5.10.1 Lokon Pharma Profile
5.10.2 Lokon Pharma Main Business
5.10.3 Lokon Pharma Oncolytic Virus Therapy Products, Services and Solutions
5.10.4 Lokon Pharma Oncolytic Virus Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Lokon Pharma Recent Developments
5.11 Genelux Corporation
5.11.1 Genelux Corporation Profile
5.11.2 Genelux Corporation Main Business
5.11.3 Genelux Corporation Oncolytic Virus Therapy Products, Services and Solutions
5.11.4 Genelux Corporation Oncolytic Virus Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Genelux Corporation Recent Developments
5.12 Vyriad
5.12.1 Vyriad Profile
5.12.2 Vyriad Main Business
5.12.3 Vyriad Oncolytic Virus Therapy Products, Services and Solutions
5.12.4 Vyriad Oncolytic Virus Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Vyriad Recent Developments
5.13 TILT Biotherapeutics
5.13.1 TILT Biotherapeutics Profile
5.13.2 TILT Biotherapeutics Main Business
5.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Products, Services and Solutions
5.13.4 TILT Biotherapeutics Oncolytic Virus Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 TILT Biotherapeutics Recent Developments
5.14 Cold Genesys
5.14.1 Cold Genesys Profile
5.14.2 Cold Genesys Main Business
5.14.3 Cold Genesys Oncolytic Virus Therapy Products, Services and Solutions
5.14.4 Cold Genesys Oncolytic Virus Therapy Revenue (US$ Million) & (2018-2023)
5.14.5 Cold Genesys Recent Developments
6 North America
6.1 North America Oncolytic Virus Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Oncolytic Virus Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Oncolytic Virus Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Oncolytic Virus Therapy Market Dynamics
11.1 Oncolytic Virus Therapy Industry Trends
11.2 Oncolytic Virus Therapy Market Drivers
11.3 Oncolytic Virus Therapy Market Challenges
11.4 Oncolytic Virus Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Latest Life Science Market Reports

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock